1997
DOI: 10.1016/s1040-7952(97)80020-1
|View full text |Cite
|
Sign up to set email alerts
|

17 Structural order of the slow and fast intrasubunit cGMP-binding sites of type Iα cGMP-dependent protein kinase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
21
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(24 citation statements)
references
References 17 publications
3
21
0
Order By: Relevance
“…Interestingly, cNMP-BD or GAF domains are arranged in tandem pairs in cGKs or PDEs respectively. In cGKI, the Nterminal cNMP-BD, designated cNMP-BD A, has been described as a high-affinity binding site, whereas cNMP-BD B has a rather low cGMP affinity [25,26]. In PDE5, the N-terminal GAF domain, GAF-A, binds cGMP, leading to activation of the enzyme [27,28].…”
Section: Figure 1 Schematic Domain Structure Of Cgmp Indicatorsmentioning
confidence: 99%
“…Interestingly, cNMP-BD or GAF domains are arranged in tandem pairs in cGKs or PDEs respectively. In cGKI, the Nterminal cNMP-BD, designated cNMP-BD A, has been described as a high-affinity binding site, whereas cNMP-BD B has a rather low cGMP affinity [25,26]. In PDE5, the N-terminal GAF domain, GAF-A, binds cGMP, leading to activation of the enzyme [27,28].…”
Section: Figure 1 Schematic Domain Structure Of Cgmp Indicatorsmentioning
confidence: 99%
“…Cyclic GMP-dependent protein kinase type I (PKG-I) 1 exists as a homodimer and is comprised of multiple functional domains. Each monomer contains a dimerization component, an autoinhibitory region, two cGMP-binding sites, and a catalytic domain (1,2).…”
mentioning
confidence: 99%
“…Each monomer contains a dimerization component, an autoinhibitory region, two cGMP-binding sites, and a catalytic domain (1,2). There are two splice variants of PKG-I, PKG-I␣ and PKG-I␤ (3-6), which show broad variation in tissue distribution (7)(8)(9)(10).…”
mentioning
confidence: 99%
“…In a fashion similar to cyclic nucleotide binding to PKA, there is a high-affinity and a low-affinity site. In PKG, these sites are the A and B-sites, respectively, unlike PKA, where the order is reversed [13, 14]. Recent crystallographic studies have discovered that the A-site in the regulatory subunit of PKG I isoforms can bind both cAMP and cGMP, although the implications for this are yet unexplored [16].…”
Section: The Cyclic Nucleotide Binding Sites In Pkg Are Discretementioning
confidence: 99%
“…First, the regulatory domains carry two in-tandem cGMP binding sites A and B (Figure 2b) [2, 4]. In contrast to PKA, the N-terminal A site is the high affinity binding site and the C-terminal B site the low affinity site in PKG [13, 14]. It has been a particular challenge to understand these compositional differences between PKA and PKG in terms of their contributions to the molecular mechanisms of kinase activation.…”
Section: Introductionmentioning
confidence: 99%